☰

Meha H. Shah, Ph.D. - Publications

Affiliations: 
2006 Johns Hopkins University, Baltimore, MD 
Area:
mechanisms of redox reactions in proteins
Tree Info Similar researchers PubMed Report error

4/287 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2006 Bekele T, Shah MH, Wolfer J, Abraham CJ, Weatherwax A, Lectka T. Catalytic, enantioselective [4 + 2]-cycloadditions of ketene enolates and o-quinones: efficient entry to chiral, alpha-oxygenated carboxylic acid derivatives. Journal of the American Chemical Society. 128: 1810-1. PMID 16464078 DOI: 10.1021/Ja058077G  0.343
2005 France S, Shah MH, Weatherwax A, Wack H, Roth JP, Lectka T. Bifunctional Lewis acid-nucleophile-based asymmetric catalysis: mechanistic evidence for imine activation working in tandem with chiral enolate formation in the synthesis of beta-lactams. Journal of the American Chemical Society. 127: 1206-15. PMID 15669860 DOI: 10.1021/Ja044179F  0.479
2004 France S, Wack H, Taggi AE, Hafez AM, Wagerle TR, Shah MH, Dusich CL, Lectka T. Catalytic, asymmetric alpha-chlorination of acid halides. Journal of the American Chemical Society. 126: 4245-55. PMID 15053614 DOI: 10.1021/Ja039046T  0.33
2003 Hafez AM, Dudding T, Wagerle TR, Shah MH, Taggi AE, Lectka T. A multistage, one-pot procedure mediated by a single catalyst: a new approach to the catalytic asymmetric synthesis of beta-amino acids. The Journal of Organic Chemistry. 68: 5819-25. PMID 12868913 DOI: 10.1021/Jo034150E  0.374
Low-probability matches (unlikely to be authored by this person)
2008 Singh P, Williams SA, Shah MH, Lectka T, Pritchard GJ, Isaacs JT, Denmeade SR. Mechanistic insights into the inhibition of prostate specific antigen by beta-lactam class compounds. Proteins. 70: 1416-28. PMID 17894328 DOI: 10.1002/Prot.21676  0.268
2003 Shah MH, France S, Lectka T. Bicarbonate Salts as Cost-Effective Bases for the Synthesis of Ketenes and Their Synthetic Equivalents Applied to the Asymmetric Synthesis of β-Lactams Synlett. 1937-1939. DOI: 10.1055/S-2003-41497  0.264
2010 Majumdar A, Sun Y, Shah M, Freel Meyers CL. Versatile (1)H-(31)P-(31)P COSY 2D NMR techniques for the characterization of polyphosphorylated small molecules. The Journal of Organic Chemistry. 75: 3214-23. PMID 20408590 DOI: 10.1021/Jo100042M  0.219
2006 Droz J, Baudin E, Medvedev V, Delord J, Kane M, Kloos R, Ringel M, Kahatt C, Weems G, Shah M. Activity of irofulven (IROF) combined with capecitabine (CAPE) in patients (pts) with advanced thyroid carcinoma: Phase II international multicenter study (preliminary results) Journal of Clinical Oncology. 24: 15511-15511. DOI: 10.1200/Jco.2006.24.18_Suppl.15511  0.164
2012 Schlumberger M, Jarzab B, Cabanillas ME, Robinson B, Pacini F, Ball DW, McCaffrey JC, Newbold K, Allison R, Martins R, Licitra LF, Shah MH, Bodenner D, Elisei R, Burmeister LA, et al. A phase II trial of the multitargeted kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer (MTC). Journal of Clinical Oncology. 30: 5591-5591. DOI: 10.1200/JCO.2012.30.15_SUPPL.5591  0.158
2006 Kloos R, Ringel M, Knopp M, Heverhagen J, Rittenberry J, Weldy L, Arbogast D, Collamore M, King M, Young D, Shah M. Significant clinical and biologic activity of RAF/VEGF-R kinase inhibitor BAY 43–9006 in patients with metastatic papillary thyroid carcinoma (PTC): Updated results of a phase II study Journal of Clinical Oncology. 24: 5534-5534. DOI: 10.1200/Jco.2006.24.18_Suppl.5534  0.158
2019 Patel SP, Othus M, Chae YK, Giles F, Hansel D, Singh P, Fontaine A, Shah M, Kasi A, Baghdadi TA, Matrana M, Gatalica Z, Korn WM, Hayward J, MMcLeod C, et al. Abstract CT039: A Phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART) S1609: The neuroendocrine cohort Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Ct039  0.153
2019 Strosberg JR, Mizuno N, Doi T, Grande E, Delord J, Shapira-Frommer R, Bergsland EK, Shah MH, Fakih M, Takahashi S, Piha-Paul SA, O'Neil B, Thomas S, Lolkema MP, Wang JD, et al. Pembrolizumab treatment of advanced neuroendocrine tumors: Results from the phase II KEYNOTE-158 study. Journal of Clinical Oncology. 37: 190-190. DOI: 10.1200/JCO.2019.37.4_SUPPL.190  0.152
2019 Xie H, Yin J, Shah MH, Menefee ME, Bible KC, Reidy-Lagunes D, Kane MA, Quinn DI, Gandara DR, Erlichman C, Adjei AA. A phase II study of the orally administered negative enantiomer of gossypol (AT-101), a BH3 mimetic, in patients with advanced adrenal cortical carcinoma. Investigational New Drugs. PMID 31172443 DOI: 10.1007/s10637-019-00797-1  0.148
2014 Qayyum MA, Shah MH. Comparative assessment of selected metals in the scalp hair and nails of lung cancer patients and controls. Biological Trace Element Research. 158: 305-22. PMID 24671620 DOI: 10.1007/s12011-014-9942-6  0.147
2013 Hobday TJ, Qin R, Moore MJ, Reidy DL, Strosberg JR, Kindler HL, Shah MH, Lenz H, Kaubisch A, Chen HX, Erlichman C. Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET). Journal of Clinical Oncology. 31: 4032-4032. DOI: 10.1200/JCO.2013.31.15_SUPPL.4032  0.147
2003 Raval GN, Patel DD, Parekh LJ, Patel JB, Shah MH, Patel PS. Evaluation of serum sialic acid, sialyltransferase and sialoproteins in oral cavity cancer. Oral Diseases. 9: 119-28. PMID 12945593 DOI: 10.1034/J.1601-0825.2003.01795.X  0.147
2017 Shah MH, Wei L, Wirth LJ, Daniels GA, De Souza JA, Timmers CD, Sexton JL, Beshara M, Nichols D, Snyder N, Devine CE, Konda B, Busaidy NL. Results of randomized phase II trial of dabrafenib versus dabrafenib plus trametinib in BRAF-mutated papillary thyroid carcinoma. Journal of Clinical Oncology. 35: 6022-6022. DOI: 10.1200/JCO.2017.35.15_SUPPL.6022  0.141
2017 Cabanillas ME, de Souza JA, Geyer S, Wirth LJ, Menefee ME, Liu SV, Shah K, Wright J, Shah MH. Cabozantinib As Salvage Therapy for Patients With Tyrosine Kinase Inhibitor-Refractory Differentiated Thyroid Cancer: Results of a Multicenter Phase II International Thyroid Oncology Group Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017730226. PMID 28817373 DOI: 10.1200/JCO.2017.73.0226  0.138
2010 Yao JC, Lombard-Bohas C, Baudin E, Kvols LK, Rougier P, Ruszniewski P, Hoosen S, St Peter J, Haas T, Lebwohl D, Van Cutsem E, Kulke MH, Hobday TJ, O'Dorisio TM, Shah MH, et al. Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 69-76. PMID 19933912 DOI: 10.1200/JCO.2009.24.2669  0.137
2010 Sipos JA, Shah MH. Thyroid cancer: emerging role for targeted therapies. Therapeutic Advances in Medical Oncology. 2: 3-16. PMID 21789122 DOI: 10.1177/1758834009352667  0.135
2009 Ramaswamy B, Phelps M, Baiocchi R, Bekaii-Saab T, Wilkins D, Arbogast D, Campbell A, Doyle AL, Grever M, Shah M. A phase I study of flavopiridol using an alternative schedule in patients (pts) with advanced solid tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 2580. PMID 27961903 DOI: 10.1200/jco.2009.27.15_suppl.2580  0.134
2014 Lerario AM, Worden FP, Ramm CA, Hesseltine EA, Hasseltine EA, Stadler WM, Else T, Shah MH, Agamah E, Rao K, Hammer GD. The combination of insulin-like growth factor receptor 1 (IGF1R) antibody cixutumumab and mitotane as a first-line therapy for patients with recurrent/metastatic adrenocortical carcinoma: a multi-institutional NCI-sponsored trial. Hormones & Cancer. 5: 232-9. PMID 24849545 DOI: 10.1007/S12672-014-0182-1  0.134
2017 Kiyota N, Robinson B, Shah MH, Hoff AO, Taylor M, Li D, Dutcus CE, Lee EK, Kim SB, Tahara M. Defining Radioiodine-refractory Differentiated Thyroid Cancer: Efficacy and Safety of Lenvatinib by Radioiodine-refractory Criteria in the SELECT Trial. Thyroid : Official Journal of the American Thyroid Association. PMID 28665259 DOI: 10.1089/thy.2016.0549  0.133
2012 Hashmi GM, Shah MH. Comparative assessment of essential and toxic metals in the blood of rheumatoid arthritis patients and healthy subjects. Biological Trace Element Research. 146: 13-22. PMID 21965111 DOI: 10.1007/s12011-011-9220-9  0.133
2018 Burkart J, Owen D, Shah MH, Abdel-Misih SRZ, Roychowdhury S, Wesolowski R, Haraldsdottir S, Reeser JW, Samorodnitsky E, Smith A, Konda B. Targeting Mutations in High-Grade Neuroendocrine Carcinoma of the Colon. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1035-1040. PMID 30181415 DOI: 10.6004/Jnccn.2018.7043  0.132
2020 Shah MH, Sherman EJ, Robinson B, Solomon BJ, Kang H, Lorch JH, Worden FP, Brose MS, Leboulleux S, Godbert Y, Meurer M, Morris JC, Owonikoko TK, Tan DS, Gautschi O, et al. Selpercatinib (LOXO-292) in patients with RET-mutant medullary thyroid cancer. Journal of Clinical Oncology. 38: 3594-3594. DOI: 10.1200/Jco.2020.38.15_Suppl.3594  0.132
2008 Varker KA, Campbell J, Shah MH. Phase II study of thalidomide in patients with metastatic carcinoid and islet cell tumors. Cancer Chemotherapy and Pharmacology. 61: 661-8. PMID 17589846 DOI: 10.1007/s00280-007-0521-9  0.131
2015 Schlumberger M, Jarzab B, Cabanillas ME, Robinson B, Pacini F, Ball DW, McCaffrey J, Newbold K, Allison R, Martins RG, Licitra LF, Shah MH, Bodenner D, Elisei R, Burmeister L, et al. A Phase II Trial of the Multitargeted Tyrosine Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26311725 DOI: 10.1158/1078-0432.CCR-15-1127  0.13
2014 Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Dutcus CE, de Las Heras B, Zhu J, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, et al. A phase 3, multicenter, double-blind, placebo-controlled trial of lenvatinib (E7080) in patients with (131)I-refractory differentiated thyroid cancer (SELECT). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 32: LBA6008. PMID 28141975 DOI: 10.1200/jco.2014.32.18_suppl.lba6008  0.129
2011 Caronia LM, Phay JE, Shah MH. Role of BRAF in thyroid oncogenesis. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 7511-7. PMID 21900390 DOI: 10.1158/1078-0432.CCR-11-1155  0.129
2018 Iyer RV, Konda B, Owen DH, Attwood K, Sarker S, Suffren S, Wilton J, Bies R, Casucci D, Reidy DL, Shah MH. Multicenter phase 2 study of nintedanib in patients (pts) with advanced progressing carcinoid tumors. Journal of Clinical Oncology. 36: 4105-4105. DOI: 10.1200/JCO.2018.36.15_SUPPL.4105  0.128
2011 Liebner DA, Shah MH. Thyroid cancer: pathogenesis and targeted therapy. Therapeutic Advances in Endocrinology and Metabolism. 2: 173-95. PMID 23148184 DOI: 10.1177/2042018811419889  0.127
2011 Shah MH, Lombard-Bohas C, Ito T, Wolin EM, Van Cutsem E, Sachs C, Winkler RE, Lincy J, Hobday TJ, Yao JC. Everolimus in patients with advanced pancreatic neuroendocrine tumors (pNET): Impact of somatostatin analog use on progression-free survival in the RADIANT-3 trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 4010. PMID 28020549 DOI: 10.1200/jco.2011.29.15_suppl.4010  0.127
2010 Phay JE, Shah MH. Targeting RET receptor tyrosine kinase activation in cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 5936-41. PMID 20930041 DOI: 10.1158/1078-0432.CCR-09-0786  0.126
2017 Owen DH, Alexander AJ, Konda B, Wei L, Hemminger JA, Schmidt CR, Abdel-Misih SRZ, Dillhoff ME, Sipos JA, Kirschner LS, Shah MH. Combination therapy with capecitabine and temozolomide in patients with low and high grade neuroendocrine tumors, with an exploratory analysis of O6-methylguanine DNA methyltransferase as a biomarker for response. Oncotarget. 8: 104046-104056. PMID 29262620 DOI: 10.18632/oncotarget.22001  0.126
2004 Shah MH, Young D, Kindler HL, Webb I, Kleiber B, Wright J, Grever M. Phase II study of the proteasome inhibitor bortezomib (PS-341) in patients with metastatic neuroendocrine tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 10: 6111-8. PMID 15447997 DOI: 10.1158/1078-0432.Ccr-04-0422  0.125
2006 Casali PG, Garrett CR, Blackstein ME, Shah M, Verweij J, McArthur G, Judson I, Li J, Baum CM, Demetri GD. Updated results from a phase III trial of sunitinib in GIST patients (pts) for whom imatinib (IM) therapy has failed due to resistance or intolerance Journal of Clinical Oncology. 24: 9513-9513. DOI: 10.1200/jco.2006.24.18_suppl.9513  0.125
2015 Lombard-Bohas C, Yao JC, Hobday T, Van Cutsem E, Wolin EM, Panneerselvam A, Stergiopoulos S, Shah MH, Capdevila J, Pommier R. Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors a subgroup analysis of the phase III RADIANT-3 trial Pancreas. 44: 181-189.  0.125
2012 Demetri GD, Garrett CR, Schöffski P, Shah MH, Verweij J, Leyvraz S, Hurwitz HI, Pousa AL, Le Cesne A, Goldstein D, Paz-Ares L, Blay JY, McArthur GA, Xu QC, Huang X, et al. Complete longitudinal analyses of the randomized, placebo-controlled, phase III trial of sunitinib in patients with gastrointestinal stromal tumor following imatinib failure. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3170-9. PMID 22661587 DOI: 10.1158/1078-0432.CCR-11-3005  0.124
2017 Konda B, Knopp MV, Martin PR, Geyer S, Cabanillas ME, De Souza JA, Wirth LJ, Menefee ME, Liu SV, Shah MH. Effect of cabozantinib on bone turnover markers (BTM) and bone metastases (BM) in radioiodine refractory (RAIR)-differentiated thyroid cancer (DTC). Journal of Clinical Oncology. 35: e17580-e17580. DOI: 10.1200/Jco.2017.35.15_Suppl.E17580  0.124
2012 Hobday TJ, Qin R, Reidy DL, Moore MJ, Strosberg JR, Kaubisch A, Shah MH, Kindler HL, Lenz HJ, Chen HX, Erlichman C. Multicenter phase II trial of temsirolimus (TEM) and bevacizumab (BEV) in pancreatic neuroendocrine tumor (PNET). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 260. PMID 27982870 DOI: 10.1200/jco.2012.30.4_suppl.260  0.124
2008 Demetri GD, Huang X, Garrett CR, Schöffski P, Blackstein ME, Shah MH, Verweij J, Tassell V, Baum CM, Casali PG. Novel statistical analysis of long-term survival to account for crossover in a phase III trial of sunitinib (SU) vs. placebo (PL) in advanced GIST after imatinib (IM) failure. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 10524. PMID 27948367 DOI: 10.1200/jco.2008.26.15_suppl.10524  0.123
2002 Nadella P, Shapiro C, Otterson GA, Hauger M, Erdal S, Kraut E, Clinton S, Shah M, Stanek M, Monk P, Villalona-Calero MA. Pharmacobiologically based scheduling of capecitabine and docetaxel results in antitumor activity in resistant human malignancies. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 20: 2616-23. PMID 12039922 DOI: 10.1200/Jco.2002.22.030  0.122
2012 Koh YW, Shah MH, Agarwal K, McCarty SK, Koo BS, Brendel VJ, Wang C, Porter K, Jarjoura D, Saji M, Ringel MD. Sorafenib and Mek inhibition is synergistic in medullary thyroid carcinoma in vitro. Endocrine-Related Cancer. 19: 29-38. PMID 22109971 DOI: 10.1530/Erc-11-0155  0.121
2008 Pasha Q, Malik SA, Shah MH. Statistical analysis of trace metals in the plasma of cancer patients versus controls. Journal of Hazardous Materials. 153: 1215-21. PMID 17997220 DOI: 10.1016/j.jhazmat.2007.09.115  0.12
2011 Saghir M, Shaheen N, Shah MH. Comparative evaluation of trace metals in the blood of hepatitis C patients and healthy donors. Biological Trace Element Research. 143: 751-63. PMID 21221841 DOI: 10.1007/s12011-010-8930-8  0.12
2020 Strosberg JR, Mizuno N, Doi T, Grande E, Delord JP, Shapira-Frommer R, Bergsland EK, Shah MH, Fakih M, Takahashi S, Piha-Paul SA, O'Neil BH, Thomas S, Lolkema M, Chen M, et al. Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Neuroendocrine Tumors: Results From the Phase 2 KEYNOTE-158 Study. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31980466 DOI: 10.1158/1078-0432.CCR-19-3014  0.12
2017 Owen DH, Patel S, Phay JE, Shirley LA, Kirschner LS, Schmidt CR, Abdel-Misih S, Brock P, Wei L, Shah MH, Konda B. Outcomes of metastatic adrenocortical carcinoma (ACC): A 16-year single institutional experience. Journal of Clinical Oncology. 35: e16088-e16088. DOI: 10.1200/JCO.2017.35.15_SUPPL.E16088  0.119
2019 Owen DH, Patel S, Wei L, Phay JE, Shirley LA, Kirschner LS, Schmidt C, Abdel-Misih S, Brock P, Shah MH, Konda B. Metastatic Adrenocortical Carcinoma: a Single Institutional Experience. Hormones & Cancer. PMID 31468469 DOI: 10.1007/s12672-019-00367-0  0.119
2015 Ilyas A, Ahmad H, Shah MH. Comparative Distribution, Correlation, and Chemometric Analyses of Selected Metals in Scalp Hair of Angina Patients and Healthy Subjects. Biological Trace Element Research. 168: 33-43. PMID 25933985 DOI: 10.1007/s12011-015-0350-3  0.119
2020 Marabelle A, Cassier PA, Fakih M, Guren TK, Italiano A, Kao SC, Nielsen D, Ascierto PA, Bariani GM, Santoro A, Shah MH, Asselah J, El-Khoueiry AB, Spencer KR, Takahashi S, et al. Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study. Journal of Clinical Oncology. 38: 1-1. DOI: 10.1200/jco.2020.38.4_suppl.1  0.118
2007 Pasha Q, Malik SA, Iqbal J, Shah MH. Characterization and distribution of the selected metals in the scalp hair of cancer patients in comparison with normal donors. Biological Trace Element Research. 118: 207-16. PMID 17916923 DOI: 10.1007/s12011-007-0035-7  0.118
2009 Woyach JA, Kloos RT, Ringel MD, Arbogast D, Collamore M, Zwiebel JA, Grever M, Villalona-Calero M, Shah MH. Lack of therapeutic effect of the histone deacetylase inhibitor vorinostat in patients with metastatic radioiodine-refractory thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 94: 164-70. PMID 18854394 DOI: 10.1210/jc.2008-1631  0.118
2015 Lombard-Bohas C, Yao JC, Hobday T, Van Cutsem E, Wolin EM, Panneerselvam A, Stergiopoulos S, Shah MH, Capdevila J, Pommier R. Impact of prior chemotherapy use on the efficacy of everolimus in patients with advanced pancreatic neuroendocrine tumors: a subgroup analysis of the phase III RADIANT-3 trial. Pancreas. 44: 181-9. PMID 25479584 DOI: 10.1097/MPA.0000000000000262  0.117
2021 Nabhan F, Kander E, Shen R, Agrawal A, Sukrithan V, Zhou Y, Goyal A, Roll K, Shah M, Konda B. Pembrolizumab in a Patient with Treatment-Naïve Unresectable BRAF-Mutation Negative Anaplastic Thyroid Cancer. Case Reports in Endocrinology. 2021: 5521649. PMID 34123437 DOI: 10.1155/2021/5521649  0.117
2014 Saleem M, Iqbal J, Shah MH. Non-carcinogenic and carcinogenic health risk assessment of selected metals in soil around a natural water reservoir, Pakistan. Ecotoxicology and Environmental Safety. 108: 42-51. PMID 25038271 DOI: 10.1016/j.ecoenv.2014.06.017  0.117
2015 Cabanillas ME, Schlumberger M, Jarzab B, Martins RG, Pacini F, Robinson B, McCaffrey JC, Shah MH, Bodenner DL, Topliss D, Andresen C, O'Brien JP, Ren M, Funahashi Y, Allison R, et al. A phase 2 trial of lenvatinib (E7080) in advanced, progressive, radioiodine-refractory, differentiated thyroid cancer: A clinical outcomes and biomarker assessment. Cancer. PMID 25913680 DOI: 10.1002/cncr.29395  0.116
2011 Schmidt C, Bloomston M, Shah MH. Well-differentiated neuroendocrine tumors: a review covering basic principles to loco-regional and targeted therapies. Oncogene. 30: 1497-505. PMID 21132004 DOI: 10.1038/onc.2010.548  0.116
2013 Iqbal J, Tirmizi SA, Shah MH. Statistical apportionment and risk assessment of selected metals in sediments from Rawal Lake (Pakistan). Environmental Monitoring and Assessment. 185: 729-43. PMID 22392618 DOI: 10.1007/s10661-012-2588-y  0.115
2009 Deprimo SE, Huang X, Blackstein ME, Garrett CR, Harmon CS, Schöffski P, Shah MH, Verweij J, Baum CM, Demetri GD. Circulating levels of soluble KIT serve as a biomarker for clinical outcome in gastrointestinal stromal tumor patients receiving sunitinib following imatinib failure. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 5869-77. PMID 19737953 DOI: 10.1158/1078-0432.CCR-08-2480  0.115
2015 Qayyum MA, Shah MH. Comparative assessment of trace metals in the blood of ovary cancer patients and controls Trace Elements and Electrolytes. 32: 65-73. DOI: 10.5414/TEX01366  0.115
2019 Marabelle A, Le DT, Ascierto PA, Di Giacomo AM, De Jesus-Acosta A, Delord JP, Geva R, Gottfried M, Penel N, Hansen AR, Piha-Paul SA, Doi T, Gao B, Chung HC, Lopez-Martin J, ... ... Shah M, et al. Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1902105. PMID 31682550 DOI: 10.1200/JCO.19.02105  0.115
2008 Shah MH, Telang SD, Shah PM, Patel PS. Tissue and serum alpha 2-3- and alpha 2-6-linkage specific sialylation changes in oral carcinogenesis. Glycoconjugate Journal. 25: 279-90. PMID 18158621 DOI: 10.1007/s10719-007-9086-4  0.114
2010 Pasha Q, Malik SA, Shaheen N, Shah MH. Investigation of trace metals in the blood plasma and scalp hair of gastrointestinal cancer patients in comparison with controls. Clinica Chimica Acta; International Journal of Clinical Chemistry. 411: 531-9. PMID 20083098 DOI: 10.1016/j.cca.2010.01.010  0.114
2010 Lam ET, Ringel MD, Kloos RT, Prior TW, Knopp MV, Liang J, Sammet S, Hall NC, Wakely PE, Vasko VV, Saji M, Snyder PJ, Wei L, Arbogast D, Collamore M, ... ... Shah MH, et al. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 28: 2323-30. PMID 20368568 DOI: 10.1200/Jco.2009.25.0068  0.114
2007 Schoffski P, Huang X, Demetri G, Casali P, Garrett C, Blackstein M, Shah M, Verweij J, Baum C, DePrimo S. 7502 ORAL Assessment of plasma levels of soluble KIT (sKIT) as a potential surrogate marker for TTP in patients (pts) with advanced gastrointestinal stromal tumor (GIST) treated with sunitinib European Journal of Cancer Supplements. 5: 402-403. DOI: 10.1016/S1359-6349(07)71479-9  0.113
2011 Yao JC, Shah MH, Ito T, Bohas CL, Wolin EM, Van Cutsem E, Hobday TJ, Okusaka T, Capdevila J, de Vries EG, Tomassetti P, Pavel ME, Hoosen S, Haas T, Lincy J, et al. Everolimus for advanced pancreatic neuroendocrine tumors. The New England Journal of Medicine. 364: 514-23. PMID 21306238 DOI: 10.1056/NEJMoa1009290  0.113
2009 Woyach JA, Shah MH. New therapeutic advances in the management of progressive thyroid cancer. Endocrine-Related Cancer. 16: 715-31. PMID 19218279 DOI: 10.1677/ERC-08-0335  0.113
2007 Blackstein M, Huang X, Demetri GD, Casali PG, Garrett CR, Schöffski P, Shah MH, Verweij J, Baum CM, DePrimo SE. Evaluation of soluble KIT (sKIT) as a potential surrogate marker for TTP in sunitinib malate (SU)-treated patients (pts) with advanced GIST Journal of Clinical Oncology. 25: 10007-10007. DOI: 10.1200/JCO.2007.25.18_SUPPL.10007  0.112
2019 Carneiro BA, Konda B, Costa RB, Costa RLB, Sagar V, Gursel DB, Kirschner LS, Chae YK, Abdulkadir SA, Rademaker A, Mahalingam D, Shah MH, Giles FJ. Nivolumab in metastatic adrenocortical carcinoma: results of a phase II trial. The Journal of Clinical Endocrinology and Metabolism. PMID 31276163 DOI: 10.1210/jc.2019-00600  0.112
2014 Fazio N, Buzzoni R, Baudin E, Antonuzzo L, Hubner R, Lahner H, De Herder WW, Raderer M, Teule A, Capdevila J, Libutti S, Kulke M, Shah M, Dey D, Turri S, et al. 1143PPH II STUDY OF BEZ235 IN PATIENTS WITH ADVANCED PANCREATIC NEUROENDOCRINE TUMORS (PNET) AFTER MTOR INHIBITOR THERAPY FAILURE: STAGE I INTERIM RESULTS. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv399. PMID 28171536 DOI: 10.1093/annonc/mdu345.12  0.111
2016 Saleem M, Iqbal J, Shah MH. Spatio-Temporal Variability and Pollution Assessment of Selected Metals in Freshwater Sediments, Pakistan Clean - Soil, Air, Water. 44: 402-410. DOI: 10.1002/clen.201400201  0.111
2017 Schlumberger M, Elisei R, Müller S, Schöffski P, Brose M, Shah M, Licitra L, Krajewska J, Kreissl MC, Niederle B, Cohen EEW, Wirth L, Ali H, Clary DO, Yaron Y, et al. Overall survival analysis of EXAM, a phase 3 trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 29045520 DOI: 10.1093/annonc/mdx479  0.111
2018 Drilon AE, Subbiah V, Oxnard GR, Bauer TM, Velcheti V, Lakhani NJ, Besse B, Park K, Patel JD, Cabanillas ME, Johnson ML, Reckamp KL, Boni V, Loong HHF, Schlumberger M, ... ... Shah MH, et al. A phase 1 study of LOXO-292, a potent and highly selective RET inhibitor, in patients with RET-altered cancers. Journal of Clinical Oncology. 36: 102-102. DOI: 10.1200/Jco.2018.36.15_Suppl.102  0.111
2008 Pasha Q, Malik SA, Iqbal J, Shaheen N, Shah MH. Comparative distribution of the scalp hair trace metal contents in the benign tumour patients and normal donors. Environmental Monitoring and Assessment. 147: 377-88. PMID 18214698 DOI: 10.1007/s10661-007-0127-z  0.111
2012 Meacham R, Matrka L, Ozer E, Ozer HG, Wakely P, Shah M. Neuroendocrine carcinoma of the head and neck: a 20-year case series. Ear, Nose, & Throat Journal. 91: E20-4. PMID 22430343 DOI: 10.1177/014556131209100317  0.111
2012 Schlumberger M, Jarzab B, Cabanillas M, Robinson B, Furio P, Ball D, McCaffrey J, Newbold K, Allison R, Martins R, Licitra L, Shah M, Bodenner D, Elisei R, Burmeister L, et al. A Phase II Trial of the Multi-Targeted Kinase Inhibitor Lenvatinib (E7080) in Advanced Medullary Thyroid Cancer (MTC) Annals of Oncology. 23: xi35-xi36. DOI: 10.1016/s0923-7534(20)32016-0  0.11
2015 Hobday TJ, Qin R, Reidy-Lagunes D, Moore MJ, Strosberg J, Kaubisch A, Shah M, Kindler HL, Lenz HJ, Chen H, Erlichman C. Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 1551-6. PMID 25488966 DOI: 10.1200/JCO.2014.56.2082  0.11
2020 Boutrid H, Kassem M, Tozbikian G, Morgan E, White J, Shah M, Vandeusen J, Sardesai S, Williams N, Stover DG, Lustberg M, Wesolowski R, Pudavalli V, Williams TM, Konda B, et al. TTF-1 Positive Primary Small Cell Carcinoma of the Breast: A Case Report and Review of the Literature. Frontiers in Endocrinology. 11: 228. PMID 32411090 DOI: 10.3389/Fendo.2020.00228  0.109
2011 Nazir R, Shaheen N, Shah MH. Indoor/outdoor relationship of trace metals in the atmospheric particulate matter of an industrial area Atmospheric Research. 101: 765-772. DOI: 10.1016/j.atmosres.2011.05.003  0.109
2010 Tariq SR, Shaheen N, Khalique A, Shah MH. Distribution, correlation, and source apportionment of selected metals in tannery effluents, related soils, and groundwater--a case study from Multan, Pakistan. Environmental Monitoring and Assessment. 166: 303-12. PMID 19484368 DOI: 10.1007/s10661-009-1003-9  0.109
2011 Saghir M, Shaheen N, Shah MH. Assessment of trace elements in the scalp hair of hepatitis-C patients in comparison with healthy donors Trace Elements and Electrolytes. 28: 213-220. DOI: 10.5414/TEX01181  0.108
2018 Nguyen MC, Shah MH, Liebner DA, Backes FJ, Phay J, Shirley LA. The Adrenal Gland as a Sanctuary Site of Metastases After Pembrolizumab Treatment: A Case Series. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 1279-1283. PMID 30442730 DOI: 10.6004/jnccn.2018.7059  0.108
2015 Schlumberger M, Elisei R, Müller S, Schöffski P, Brose MS, Shah MH, Licitra LF, Jarzab B, Medvedev V, Kreissl M, Cohen EEW, Wirth LJ, Ali HY, Hessel C, Yaron Y, et al. Final overall survival analysis of EXAM, an international, double-blind, randomized, placebo-controlled phase III trial of cabozantinib (Cabo) in medullary thyroid carcinoma (MTC) patients with documented RECIST progression at baseline. Journal of Clinical Oncology. 33: 6012-6012. DOI: 10.1200/JCO.2015.33.15_SUPPL.6012  0.108
2006 Khalique A, Shah MH, Jaffar M, Shaheen N, Tariq SR, Manzoor S. Multivariate analysis of the selected metals in the hair of cerebral palsy patients versus controls. Biological Trace Element Research. 111: 11-22. PMID 16943593 DOI: 10.1385/BTER:111:1:11  0.108
2012 Choti MA, Mayorga MA, Bobiak S, Kulke M, Yao JC, Bergsland EK, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR. Baseline demographics of patients with neuroendocrine tumors presenting to seven National Comprehensive Cancer Network (NCCN) institutions: Development of a multi-institutional outcomes database. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 187. PMID 27983443 DOI: 10.1200/Jco.2012.30.4_Suppl.187  0.106
2013 Abbasi AM, Iqbal J, Khan MA, Shah MH. Health risk assessment and multivariate apportionment of trace metals in wild leafy vegetables from Lesser Himalayas, Pakistan. Ecotoxicology and Environmental Safety. 92: 237-44. PMID 23490195 DOI: 10.1016/j.ecoenv.2013.02.011  0.106
2006 Shah MH, Binkley P, Chan K, Xiao J, Arbogast D, Collamore M, Farra Y, Young D, Grever M. Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3997-4003. PMID 16818698 DOI: 10.1158/1078-0432.Ccr-05-2689  0.106
2021 Bible KC, Kebebew E, Brierley J, Brito JP, Cabanillas ME, Clark TJ, Di Cristofano A, Foote R, Giordano T, Kasperbauer J, Newbold K, Nikiforov YE, Randolph G, Rosenthal MS, Sawka AM, ... Shah M, et al. 2021 American Thyroid Association Guidelines for Management of Patients with Anaplastic Thyroid Cancer. Thyroid : Official Journal of the American Thyroid Association. 31: 337-386. PMID 33728999 DOI: 10.1089/thy.2020.0944  0.106
2012 Ramaswamy B, Phelps MA, Baiocchi R, Bekaii-Saab T, Ni W, Lai JP, Wolfson A, Lustberg ME, Wei L, Wilkins D, Campbell A, Arbogast D, Doyle A, Byrd JC, Grever MR, ... Shah MH, et al. A dose-finding, pharmacokinetic and pharmacodynamic study of a novel schedule of flavopiridol in patients with advanced solid tumors. Investigational New Drugs. 30: 629-38. PMID 20938713 DOI: 10.1007/s10637-010-9563-7  0.106
2016 Iqbal J, Saleem M, Shah MH. Spatial distribution, environmental assessment and source identification of metals content in surface sediments of freshwater reservoir, Pakistan Chemie Der Erde - Geochemistry. 76: 171-177. DOI: 10.1016/j.chemer.2016.02.002  0.105
2012 Iqbal J, Tirmizi SA, Shah MH. Non-carcinogenic health risk assessment and source apportionment of selected metals in source freshwater Khanpur Lake, Pakistan. Bulletin of Environmental Contamination and Toxicology. 88: 177-81. PMID 22120698 DOI: 10.1007/s00128-011-0480-z  0.105
2017 Haddad RI, Schlumberger M, Wirth LJ, Sherman EJ, Shah MH, Robinson B, Dutcus CE, Teng A, Gianoukakis AG, Sherman SI. Incidence and timing of common adverse events in Lenvatinib-treated patients from the SELECT trial and their association with survival outcomes. Endocrine. PMID 28155175 DOI: 10.1007/s12020-017-1233-5  0.103
2014 Iqbal J, Shah MH. Study of seasonal variations and health risk assessment of heavy metals in Cyprinus carpio from Rawal Lake, Pakistan. Environmental Monitoring and Assessment. 186: 2025-37. PMID 24213637 DOI: 10.1007/s10661-013-3515-6  0.103
2012 Jones NB, Shah MH, Bloomston M. Liver-directed therapies in patients with advanced neuroendocrine tumors. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 765-74. PMID 22679118  0.103
2011 Sherman SI, Jarzab B, Cabanillas ME, Licitra LF, Pacini F, Martins R, Robinson B, Ball D, McCaffrey J, Shah MH, Bodenner D, Allison R, Newbold K, Elisei R, O'Brien JP, et al. A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5503. PMID 28021459 DOI: 10.1200/jco.2011.29.15_suppl.5503  0.103
2005 Otterson GA, Lavelle J, Villalona-Calero MA, Shah M, Wei X, Chan KK, Fischer B, Grever M. A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors Investigational New Drugs. 23: 555-562. PMID 16034523 DOI: 10.1007/s10637-005-1665-2  0.102
2014 Elisei R, Schlumberger M, Tahara M, Robinson B, Brose M, Dutcus C, Heras BD, Zhu J, Habra MA, Newbold K, Shah M, Hoff AO, Gianoukakis A, Kiyota N, Taylor MH, et al. 1033PSUBGROUP ANALYSES OF A PHASE 3, MULTICENTER, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF LENVATINIB (E7080) IN PATIENTS WITH 131I-REFRACTORY DIFFERENTIATED THYROID CANCER. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv355. PMID 28171080 DOI: 10.1093/annonc/mdu340.48  0.102
2009 Shah MH, Varker KA, Collamore M, Zwiebel JA, Coit D, Kelsen D, Chung KY. G3139 (Genasense) in patients with advanced merkel cell carcinoma. American Journal of Clinical Oncology. 32: 174-9. PMID 19307957 DOI: 10.1097/COC.0b013e31817eebf8  0.102
2008 Pasha Q, Malik SA, Iqbal J, Shaheen N, Shah MH. Comparative evaluation of trace metal distribution and correlation in human malignant and benign breast tissues. Biological Trace Element Research. 125: 30-40. PMID 18496653 DOI: 10.1007/s12011-008-8158-z  0.102
2020 Cabanillas ME, Wirth LJ, Sherman EJ, Drilon A, Solomon B, Robinson BG, Lorch JH, McCoach C, Patel J, Leboulleux S, Worden F, Owonikoko TK, Brose MS, Taylor MH, Subbiah V, ... ... Shah MH, et al. SUN-LB75 The Anti-Tumor Activity of the Selective Ret Inhibitor Selpercatinib (LOXO-292) in Medullary Thyroid Cancer Is Independent of the Specific RET Mutation Journal of the Endocrine Society. 4. DOI: 10.1210/jendso/bvaa046.2223  0.101
2013 Smallridge RC, Copland JA, Brose MS, Wadsworth JT, Houvras Y, Menefee ME, Bible KC, Shah MH, Gramza AW, Klopper JP, Marlow LA, Heckman MG, Von Roemeling R. Efatutazone, an oral PPAR-γ agonist, in combination with paclitaxel in anaplastic thyroid cancer: results of a multicenter phase 1 trial. The Journal of Clinical Endocrinology and Metabolism. 98: 2392-400. PMID 23589525 DOI: 10.1210/jc.2013-1106  0.101
2009 Kloos RT, Ringel MD, Knopp MV, Hall NC, King M, Stevens R, Liang J, Wakely PE, Vasko VV, Saji M, Rittenberry J, Wei L, Arbogast D, Collamore M, Wright JJ, ... ... Shah MH, et al. Phase II trial of sorafenib in metastatic thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 27: 1675-84. PMID 19255327 DOI: 10.1200/Jco.2008.18.2717  0.101
2018 Cloyd JM, Konda B, Shah MH, Pawlik TM. The Emerging Role of Targeted Therapies for Advanced Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors. Expert Review of Clinical Pharmacology. PMID 30582383 DOI: 10.1080/17512433.2019.1561273  0.101
2020 Patel SP, Othus M, Chae YK, Giles FJ, Hansel DE, Singh PP, Fontaine A, Shah MH, Kasi A, Al Baghdadi T, Matrana M, Gatalica Z, Korn WM, Hayward J, McLeod C, et al. A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Non-Pancreatic Neuroendocrine Tumors. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 31969335 DOI: 10.1158/1078-0432.Ccr-19-3356  0.1
2016 Shah MH, Lorigan P, O'Brien ME, Fossella FV, Moore KN, Bhatia S, Kirby M, Woll PJ. Phase I study of IMGN901, a CD56-targeting antibody-drug conjugate, in patients with CD56-positive solid tumors. Investigational New Drugs. PMID 26961907 DOI: 10.1007/s10637-016-0336-9  0.099
2019 Konda B, Rogers SC, Grenade CN, Verschraegen CF, Zhou Y, Goyal A, Natwa M, Wright C, Hussein A, Barr H, Konate D, Brown A, Batdorf R, Williams B, Zhao S, ... ... Shah MH, et al. First real-world experience of peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors (NET) since US FDA approval. Journal of Clinical Oncology. 37: e15691-e15691. DOI: 10.1200/Jco.2019.37.15_Suppl.E15691  0.099
2012 Shah MH, Iqbal J, Shaheen N, Khan N, Choudhary MA, Akhter G. Assessment of background levels of trace metals in water and soil from a remote region of Himalaya. Environmental Monitoring and Assessment. 184: 1243-52. PMID 21625922 DOI: 10.1007/s10661-011-2036-4  0.099
2006 Demetri GD, van Oosterom AT, Garrett CR, Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich MC, Morgan JA, Desai J, Fletcher CD, George S, Bello CL, Huang X, et al. Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial. Lancet. 368: 1329-38. PMID 17046465 DOI: 10.1016/S0140-6736(06)69446-4  0.099
2015 Kiyota N, Robinson B, Shah M, Hoff A, Taylor M, Li D, Dutcus C, Lee E, Kim S, Tahara M. 2864 Defining 131I-refractory differentiated thyroid cancer: efficacy and safety of lenvatinib by 131I-refractory criteria in the SELECT trial European Journal of Cancer. 51: S578. DOI: 10.1016/S0959-8049(16)31602-1  0.098
2012 Smallridge RC, Ain KB, Asa SL, Bible KC, Brierley JD, Burman KD, Kebebew E, Lee NY, Nikiforov YE, Rosenthal MS, Shah MH, Shaha AR, Tuttle RM. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 22: 1104-39. PMID 23130564 DOI: 10.1089/thy.2012.0302  0.098
2015 Van Loon K, Zhang L, Creasman JM, Choti MA, Yao JC, Kulke MH, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Zornosa CC, Bobiak S, Bergsland EK. Recurrence following surgical resection of gastroenteropancreatic neuroendocrine tumors (NETs): An analysis from the NCCN oncology outcomes database. Journal of Clinical Oncology. 33: 4107-4107. DOI: 10.1200/Jco.2015.33.15_Suppl.4107  0.098
2021 Sukrithan V, Husain M, Kirschner L, Shah MH, Konda B. Emerging drugs for the treatment of Adrenocortical Carcinoma. Expert Opinion On Emerging Drugs. PMID 33896321 DOI: 10.1080/14728214.2021.1920922  0.098
2018 Oxnard G, Subbiah V, Park K, Bauer T, Wirth L, Velcheti V, Shah M, Besse B, Boni V, Reckamp K, Loong H, Bazhenova L, Solomon B, Tan D, Patel J, et al. OA12.07 Clinical Activity of LOXO-292, a Highly Selective RET Inhibitor, in Patients with RET Fusion+ Non-Small Cell Lung Cancer Journal of Thoracic Oncology. 13: S349-S350. DOI: 10.1016/J.Jtho.2018.08.304  0.097
2012 Abuzakhm S, Bloomston M, Shah MH. Uncommon Cancers of the Thyroid Textbook of Uncommon Cancer. 189-200. DOI: 10.1002/9781118464557.ch11  0.097
2014 Qayyum MA, Shah MH. Comparative study of trace elements in blood, scalp hair and nails of prostate cancer patients in relation to healthy donors. Biological Trace Element Research. 162: 46-57. PMID 25231348 DOI: 10.1007/s12011-014-0123-4  0.097
2011 Iqbal J, Shah MH. Distribution, correlation and risk assessment of selected metals in urban soils from Islamabad, Pakistan. Journal of Hazardous Materials. 192: 887-98. PMID 21724324 DOI: 10.1016/j.jhazmat.2011.05.105  0.097
2006 Sainger RNS, Shah MH, Desai AA, Shukla SN, Shah PM, Telang SD, Patel PS. Clinical Significance of Serum p53 Antibodies in Oral Cancer Tumori Journal. 92: 134-139. DOI: 10.1177/030089160609200209  0.097
2011 Hashmi GMM, Shah MH. Comparative evaluation of trace elements in the scalp hair of arthritis patients and healthy donors Toxicological and Environmental Chemistry. 93: 2123-2134. DOI: 10.1080/02772248.2011.626417  0.096
2014 Saleem M, Iqbal J, Shah MH. Dissolved concentrations, sources, and risk evaluation of selected metals in surface water from Mangla Lake, Pakistan. Thescientificworldjournal. 2014: 948396. PMID 24744690 DOI: 10.1155/2014/948396  0.096
2005 Demetri GD, van Oosterom AT, Blackstein M, Garrett C, Shah M, Heinrich M, McArthur G, Judson I, Baum CM, Casali PG. Phase 3, multicenter, randomized, double-blind, placebo-controlled trial of SU11248 in patients (pts) following failure of imatinib for metastatic GIST Journal of Clinical Oncology. 23: 4000-4000. DOI: 10.1200/jco.2005.23.16_suppl.4000  0.096
2020 Wirth LJ, Sherman E, Robinson B, Solomon B, Kang H, Lorch J, Worden F, Brose M, Patel J, Leboulleux S, Godbert Y, Barlesi F, Morris JC, Owonikoko TK, Tan DSW, ... ... Shah MH, et al. Efficacy of Selpercatinib in -Altered Thyroid Cancers. The New England Journal of Medicine. 383: 825-835. PMID 32846061 DOI: 10.1056/Nejmoa2005651  0.096
2018 Strosberg D, Schneider EB, Onesti J, Saunders N, Konda B, Shah M, Dillhoff M, Schmidt CR, Shirley LA. Prognostic Impact of Serum Pancreastatin Following Chemoembolization for Neuroendocrine Tumors. Annals of Surgical Oncology. PMID 30182331 DOI: 10.1245/s10434-018-6741-x  0.096
2007 Arce-Lara C, Shah MH, Jimenez RE, Patel VR, Benson DM, Clinton SK, Monk JP. Gastrointestinal stromal tumors involving the prostate: presentation, course, and therapeutic approach. Urology. 69: 1209.e5-7. PMID 17572224 DOI: 10.1016/J.Urology.2007.03.029  0.095
2014 Haraldsdottir S, Shah MH. An update on clinical trials of targeted therapies in thyroid cancer. Current Opinion in Oncology. 26: 36-44. PMID 24240178 DOI: 10.1097/CCO.0000000000000029  0.095
2015 Newbold K, Elisei R, Taylor MH, Krzyzanowska MK, Shah MH, Hoff AO, Robinson B, Dutcus C, Song J, Habra MA. Efficacy and safety of lenvatinib for the treatment of patients with 131I-refractory differentiated thyroid cancer with and without prior VEGF-targeted therapy. Journal of Clinical Oncology. 33: 6013-6013. DOI: 10.1200/JCO.2015.33.15_SUPPL.6013  0.094
2019 Wirth L, Sherman E, Drilon A, Solomon B, Robinson B, Lorch J, McCoach C, Patel J, Leboulleux S, Worden F, Owonikoko T, Brose M, Taylor M, Italiano A, Gautschi O, ... ... Shah M, et al. Registrational results of LOXO-292 in patients with RET-altered thyroid cancers Annals of Oncology. 30: v933. DOI: 10.1093/annonc/mdz394.093  0.094
2007 Varker KA, Martin EW, Klemanski D, Palmer B, Shah MH, Bloomston M. Repeat transarterial chemoembolization (TACE) for progressive hepatic carcinoid metastases provides results similar to first TACE. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 11: 1680-5. PMID 17899303 DOI: 10.1007/s11605-007-0235-7  0.094
2010 Anthony LB, Loehrer PJ, Leong S, Shah MH, Safran H, Senzer NN, Zojwalla NJ, Youssoufian H. Phase II study of cixutumumab (IMC-A12) plus depot octreotide for patients with metastatic carcinoid or islet cell carcinoma. Journal of Clinical Oncology. 28: TPS220-TPS220. DOI: 10.1200/JCO.2010.28.15_SUPPL.TPS220  0.094
2013 Elisei R, Schlumberger MJ, Müller SP, Schöffski P, Brose MS, Shah MH, Licitra L, Jarzab B, Medvedev V, Kreissl MC, Niederle B, Cohen EE, Wirth LJ, Ali H, Hessel C, et al. Cabozantinib in progressive medullary thyroid cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 31: 3639-46. PMID 24002501 DOI: 10.1200/JCO.2012.48.4659  0.093
2019 Owen DH, Konda B, Sipos J, Liu T, Webb A, Ringel MD, Timmers CD, Shah MH. KRAS G12V Mutation in Acquired Resistance to Combined BRAF and MEK Inhibition in Papillary Thyroid Cancer. Journal of the National Comprehensive Cancer Network : Jnccn. 17: 409-413. PMID 31085763 DOI: 10.6004/jnccn.2019.7292  0.093
2012 Yao J, Shah M, Panneerselvam A, Stergiopoulos S, Chen D, Ito T, Pavel M. The Vegf Pathway in Patients with Pancreatic Neuroendocrine Tumors: Efficacy of Everolimus by Baseline Marker Level, and Prognostic and Predictive Effect Analyses from Radiant-3 Annals of Oncology. 23: ix376. DOI: 10.1093/ANNONC/MDS405  0.093
2020 Marabelle A, Fakih M, Lopez J, Shah M, Shapira-Frommer R, Nakagawa K, Chung HC, Kindler HL, Lopez-Martin JA, Miller WH, Italiano A, Kao S, Piha-Paul SA, Delord JP, McWilliams RR, et al. Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study. The Lancet. Oncology. PMID 32919526 DOI: 10.1016/S1470-2045(20)30445-9  0.092
2015 Schlumberger M, Tahara M, Wirth LJ, Robinson B, Brose MS, Elisei R, Habra MA, Newbold K, Shah MH, Hoff AO, Gianoukakis AG, Kiyota N, Taylor MH, Kim SB, Krzyzanowska MK, et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. The New England Journal of Medicine. 372: 621-30. PMID 25671254 DOI: 10.1056/NEJMoa1406470  0.092
2007 Shah MH, Shaheen N. Statistical analysis of atmospheric trace metals and particulate fractions in Islamabad, Pakistan. Journal of Hazardous Materials. 147: 759-67. PMID 17320287 DOI: 10.1016/j.jhazmat.2007.01.075  0.092
2015 Boltz K, Shah MH, Cohen EEW, Cabanillas ME. Targeted and Salvage Therapies Benefit Patients With Thyroid Cancer Md Conference Express. 15: 25-26. DOI: 10.1177/1559897715581829  0.091
2018 Shah MH, Goldner WS, Halfdanarson TR, Bergsland E, Berlin JD, Halperin D, Chan J, Kulke MH, Benson AB, Blaszkowsky LS, Eads J, Engstrom PF, Fanta P, Giordano T, He J, et al. NCCN Guidelines Insights: Neuroendocrine and Adrenal Tumors, Version 2.2018. Journal of the National Comprehensive Cancer Network : Jnccn. 16: 693-702. PMID 29891520 DOI: 10.6004/Jnccn.2018.0056  0.091
2009 Majumdar A, Shah MH, Bitok JK, Hassis-LeBeau ME, Freel Meyers CL. Probing phosphorylation by non-mammalian isoprenoid biosynthetic enzymes using (1)H-(31)P-(31)P correlation NMR spectroscopy. Molecular Biosystems. 5: 935-44. PMID 19668858 DOI: 10.1039/b903513c  0.091
2012 Scaduto M, Matrka L, Shah M, Wakely P, Ozer E. Poorly differentiated small-cell neuroendocrine carcinoma of the submandibular gland: a case report. Ear, Nose, & Throat Journal. 91: E10-3. PMID 22522359 DOI: 10.1177/014556131209100416  0.09
2015 Abbasi AM, Shah MH, Khan MA. Wild edible vegetables of lesser himalayas: Ethnobotanical and nutraceutical aspects, volume 1 Wild Edible Vegetables of Lesser Himalayas: Ethnobotanical and Nutraceutical Aspects, Volume 1. 1-360. DOI: 10.1007/978-3-319-09543-1  0.089
2012 Shah MH, Shaheen N, Nazir R. Assessment of the trace elements level in urban atmospheric particulate matter and source apportionment in Islamabad, Pakistan Atmospheric Pollution Research. 3: 39-45. DOI: 10.5094/APR.2012.003  0.089
2020 Squires MH, Worth PJ, Konda B, Shah MH, Dillhoff ME, Abdel-Misih S, Norton JA, Visser BC, Dua M, Pawlik TM, Schmidt CR, Poultsides G, Cloyd JM. Neoadjuvant Capecitabine/Temozolomide for Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors. Pancreas. PMID 32132509 DOI: 10.1097/Mpa.0000000000001500  0.089
2008 Tariq SR, Shah MH, Shaheen N, Jaffar M, Khalique A. Statistical source identification of metals in groundwater exposed to industrial contamination. Environmental Monitoring and Assessment. 138: 159-65. PMID 17492482 DOI: 10.1007/s10661-007-9753-8  0.088
2015 Kulke MH, Shah MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Emerson L, Engstrom PF, Fanta P, Giordano T, Goldner WS, Halfdanarson TR, Heslin MJ, Kandeel F, Kunz PL, et al. Neuroendocrine tumors, version 1.2015. Journal of the National Comprehensive Cancer Network : Jnccn. 13: 78-108. PMID 25583772  0.088
2016 Kitano M, Davidson GW, Shirley LA, Schmidt CR, Guy GE, Khabiri H, Dowell JD, Shah MH, Bloomston M. Transarterial Chemoembolization for Metastatic Neuroendocrine Tumors With Massive Hepatic Tumor Burden: Is the Benefit Worth the Risk? Annals of Surgical Oncology. PMID 27393568 DOI: 10.1245/S10434-016-5333-X  0.088
2015 Kavecansky J, Wei L, Caronia L, Ramirez MT, Bloomston M, Shah MH. Bone metastases in well-to-moderately differentiated neuroendocrine tumors: a single institutional review from the Ohio State University Medical Center. Pancreas. 44: 198-203. PMID 25411805 DOI: 10.1097/MPA.0000000000000267  0.087
2006 Monk JP, Phillips G, Waite R, Kuhn J, Schaaf LJ, Otterson GA, Guttridge D, Rhoades C, Shah M, Criswell T, Caligiuri MA, Villalona-Calero MA. Assessment of tumor necrosis factor alpha blockade as an intervention to improve tolerability of dose-intensive chemotherapy in cancer patients. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 24: 1852-9. PMID 16622259 DOI: 10.1200/Jco.2005.04.2838  0.087
2015 Saleem M, Iqbal J, Shah MH. Geochemical speciation, anthropogenic contamination, risk assessment and source identification of selected metals in freshwater sediments - A case study from Mangla Lake, Pakistan Environmental Nanotechnology, Monitoring and Management. 4: 27-36. DOI: 10.1016/j.enmm.2015.02.002  0.086
2020 Brock P, Bustamante Alvarez J, Mortazavi A, Roychowdhury S, Phay J, Khawaja RA, Shah MH, Konda B. Co-occurrence of multiple endocrine neoplasia type 4 and spinal neurofibromatosis: a case report. Familial Cancer. PMID 32052251 DOI: 10.1007/S10689-019-00152-6  0.086
2021 Chan H, Zhang L, Choti MA, Kulke M, Yao JC, Nakakura EK, Bloomston M, Benson AB, Shah MH, Strosberg JR, Bergsland EK, Van Loon K. Recurrence Patterns After Surgical Resection of Gastroenteropancreatic Neuroendocrine Tumors: Analysis From the National Comprehensive Cancer Network Oncology Outcomes Database. Pancreas. 50: 506-512. PMID 33939661 DOI: 10.1097/MPA.0000000000001791  0.086
2010 Pasha Q, Malik SA, Shaheen N, Shah MH. Comparison of trace elements in the scalp hair of malignant and benign breast lesions versus healthy women. Biological Trace Element Research. 134: 160-73. PMID 19644659 DOI: 10.1007/s12011-009-8469-8  0.085
2012 Begum S, Shah MH, Nauman M. Preparation of aluminum hydroxide from bauxite with alkaline additives Journal of the Chemical Society of Pakistan. 34: 76-80.  0.085
2014 Haraldsdottir S, Janku F, Timmers CD, Geyer SM, Schaaf LJ, Sexton JL, Thurmond J, Bravo VMV, Stepanek VMT, Bertino EM, Kendra KL, Mortazavi A, Subbiah V, Poi M, Phelps MA, ... Shah MH, et al. A phase I trial of dabrafenib (BRAF inhibitor) and pazopanib in BRAF-mutated advanced malignancies. Journal of Clinical Oncology. 32. DOI: 10.1200/Jco.2014.32.15_Suppl.Tps2628  0.085
2013 Iqbal J, Shah MH, Akhter G. Characterization, source apportionment and health risk assessment of trace metals in freshwater Rawal Lake, Pakistan Journal of Geochemical Exploration. 125: 94-101. DOI: 10.1016/j.gexplo.2012.11.009  0.084
2006 Mrozek E, Kloos RT, Ringel MD, Kresty L, Snider P, Arbogast D, Kies M, Munden R, Busaidy N, Klein MJ, Sherman SI, Shah MH. Phase II study of celecoxib in metastatic differentiated thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. 91: 2201-4. PMID 16522694 DOI: 10.1210/jc.2005-2498  0.084
2015 Ilyas A, Shah MH. Abnormalities of selected trace elements in patients with coronary artery disease Acta Cardiologica Sinica. 31: 518-527. DOI: 10.6515/ACS20150302A  0.084
2009 Tariq SR, Shah MH, Shaheen N. Comparative statistical analysis of chrome and vegetable tanning effluents and their effects on related soil. Journal of Hazardous Materials. 169: 285-90. PMID 19376649 DOI: 10.1016/j.jhazmat.2009.03.093  0.083
2012 Wright CL, Werner JD, Tran JM, Gates VL, Rikabi AA, Shah MH, Salem R. Radiation pneumonitis following yttrium-90 radioembolization: case report and literature review. Journal of Vascular and Interventional Radiology : Jvir. 23: 669-74. PMID 22525023 DOI: 10.1016/J.Jvir.2012.01.059  0.083
2021 Owen D, Wei L, Pilcher C, Patel S, Konda B, Shah M, Ferguson S, Benner B, Norman R, Carson W, Smith M, Vogt SM, Verschraegen C, He K, Bertino E, et al. P79.04 A Phase 2 Trial of Nivolumab and Temozolomide in Extensive Stage Small Cell Lung Cancer: Interim Efficacy Analysis. Journal of Thoracic Oncology. 16: S647. DOI: 10.1016/J.JTHO.2021.01.1183  0.083
2013 Saleem M, Iqbal J, Shah MH. Study of seasonal variations and risk assessment of selected metals in sediments from Mangla Lake, Pakistan Journal of Geochemical Exploration. 125: 144-152. DOI: 10.1016/j.gexplo.2012.12.006  0.082
2006 Bloomston M, Muscarella P, Shah MH, Frankel WL, Al-Saif O, Martin EW, Ellison EC. Cytoreduction results in high perioperative mortality and decreased survival in patients undergoing pancreatectomy for neuroendocrine tumors of the pancreas. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 10: 1361-70. PMID 17175455 DOI: 10.1016/j.gassur.2006.09.004  0.082
2015 Shirley LA, McNally M, Chokshi R, Jones N, Tassone P, Guy G, Khabiri H, Schmidt C, Shah M, Bloomston M. Transarterial chemoembolization is ineffective for neuroendocrine tumors metastatic to the caudate lobe: a single institution review. World Journal of Surgical Oncology. 13: 167. PMID 25927667 DOI: 10.1186/s12957-015-0551-4  0.082
2015 Iqbal J, Shah MH, Shaheen N. Distribution, source identification and risk assessment of selected metals in sediments from freshwater lake International Journal of Sediment Research. 30: 241-249. DOI: 10.1016/j.ijsrc.2012.12.001  0.081
2015 Iqbal J, Shah MH. Study of selected metals distribution, source apportionment, and risk assessment in suburban soil, Pakistan Journal of Chemistry. 2015. DOI: 10.1155/2015/481324  0.081
2012 Colevas AD, Shah MH. Evaluation of patients with disseminated or locoregionally advanced thyroid cancer: a primer for medical oncologists. American Society of Clinical Oncology Educational Book / Asco. American Society of Clinical Oncology. Meeting. 384-8. PMID 24451768 DOI: 10.14694/EdBook_AM.2012.32.384  0.081
2014 Ahmed F, Shah MH, Shaheen N. Diurnal and nocturnal variations of trace metals in urban atmospheric particulate matter from Islamabad, Pakistan Environmental Earth Sciences. 71: 817-826. DOI: 10.1007/s12665-013-2484-y  0.08
2008 Shah M, Telang S, Raval G, Shah P, Patel PS. Serum fucosylation changes in oral cancer and oral precancerous conditions: alpha-L-fucosidase as a marker. Cancer. 113: 336-46. PMID 18521898 DOI: 10.1002/cncr.23556  0.08
2012 Iqbal J, Shah MH. Water quality evaluation, health risk assessment and multivariate apportionment of selected elements from Simly Lake, Pakistan Water Science and Technology: Water Supply. 12: 588-594. DOI: 10.2166/ws.2012.019  0.08
2012 Kulke MH, Benson AB, Bergsland E, Berlin JD, Blaszkowsky LS, Choti MA, Clark OH, Doherty GM, Eason J, Emerson L, Engstrom PF, Goldner WS, Heslin MJ, Kandeel F, Kunz PL, ... ... Shah MH, et al. Neuroendocrine tumors. Journal of the National Comprehensive Cancer Network : Jnccn. 10: 724-64. PMID 22679117 DOI: 10.6004/JNCCN.2012.0075  0.08
2019 Drilon A, Oxnard G, Wirth L, Besse B, Gautschi O, Tan SWD, Loong H, Bauer T, Kim YJ, Horiike A, Park K, Shah M, McCoach C, Bazhenova L, Seto T, et al. PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers Journal of Thoracic Oncology. 14. DOI: 10.1016/J.Jtho.2019.08.059  0.08
2017 Velcheti V, Bauer T, Subbiah V, Cabanillas M, Lakhani N, Wirth L, Oxnard G, Shah M, Sherman E, Smith S, Eary T, Cruickshank S, Tuch B, Ebata K, Nguyen M, et al. OA 12.07 LOXO-292, a Potent, Highly Selective RET Inhibitor, in MKI-Resistant RET Fusion-Positive Lung Cancer Patients with and without Brain Metastases Journal of Thoracic Oncology. 12: S1778. DOI: 10.1016/J.Jtho.2017.09.399  0.079
2014 Haraldsdottir S, Shah MH. New era for treatment in differentiated thyroid cancer. Lancet (London, England). 384: 286-8. PMID 24768111 DOI: 10.1016/S0140-6736(14)60663-2  0.079
2012 Chabukswar AR, Thakur VG, Dharam DL, Shah MH, Kuchekar BS, Sharma SN. Development and validation of HPTLC method for simultaneous estimation of paracetamol, ibuprofen and caffeine in bulk and pharmaceutical dosage form Research Journal of Pharmacy and Technology. 5: 1218-1222.  0.079
2010 Sparano JA, Lee JY, Kaplan LD, Levine AM, Ramos JC, Ambinder RF, Wachsman W, Aboulafia D, Noy A, Henry DH, Von Roenn J, Dezube BJ, Remick SC, Shah MH, Leichman L, et al. Rituximab plus concurrent infusional EPOCH chemotherapy is highly effective in HIV-associated B-cell non-Hodgkin lymphoma. Blood. 115: 3008-16. PMID 20023215 DOI: 10.1182/Blood-2009-08-231613  0.078
2007 Villalona-Calero M, Schaaf L, Phillips G, Otterson G, Panico K, Duan W, Kleiber B, Shah M, Young D, Wu WH, Kuhn J. Thalidomide and celecoxib as potential modulators of irinotecan's activity in cancer patients. Cancer Chemotherapy and Pharmacology. 59: 23-33. PMID 16685529 DOI: 10.1007/s00280-006-0249-y  0.077
2006 Shah MH, Biradar SV, Paradkar AR. Spray dried glyceryl monooleate-magnesium trisilicate dry powder as cubic phase precursor. International Journal of Pharmaceutics. 323: 18-26. PMID 16846704 DOI: 10.1016/j.ijpharm.2006.05.040  0.077
2009 Clark OH, Benson AB, Berlin JD, Choti MA, Doherty GM, Engstrom PF, Gibbs JF, Heslin MJ, Kessinger A, Kulke MH, Kvols L, Salem R, Saltz L, Shah MH, Shibata S, et al. NCCN Clinical Practice Guidelines in Oncology: neuroendocrine tumors. Journal of the National Comprehensive Cancer Network : Jnccn. 7: 712-47. PMID 19635226  0.077
2015 Onesti JK, Shirley LA, Saunders ND, Davidson GW, Dillhoff ME, Khabiri H, Guy GE, Dowell JD, Schmidt CR, Shah MH, Bloomston M. Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. PMID 26489743 DOI: 10.1007/S11605-015-2998-6  0.076
2012 Hussain N, Shah MH, Amini-Harandi A, Akhtar Z. Common fixed point theorems for generalized contractive mappings with applications Fixed Point Theory and Applications. 2013. DOI: 10.1186/1687-1812-2013-169  0.076
2019 Marabelle A, Fakih MG, Lopez J, Shah M, Shapira-Frommer R, Nakagawa K, Chung HC, Kindler HL, Lopez-Martin JA, Miller W, Italiano A, Kao S, Piha-Paul SA, Delord J-, McWilliams RR, et al. Association of tumour mutational burden with outcomes in patients with select advanced solid tumours treated with pembrolizumab in KEYNOTE-158 Annals of Oncology. 30. DOI: 10.1093/Annonc/Mdz253.018  0.076
2009 Biradar SV, Dhumal RS, Shah MH, Paradkar AR, Yamamura S. Preparation of multiparticulate vaginal tablet using glyceryl monooleate for sustained progesterone delivery. Pharmaceutical Development and Technology. 14: 38-49. PMID 18802845 DOI: 10.1080/10837450802409396  0.076
2017 Konda B, Nabhan F, Shah MH. Endocrine dysfunction following immune checkpoint inhibitor therapy. Current Opinion in Endocrinology, Diabetes, and Obesity. PMID 28661915 DOI: 10.1097/MED.0000000000000357  0.076
2011 Moley JF, Adkins D, Bible KC, Traynor AM, Molina JR, Colon-Otero G, Pluard TJ, Shah MH, Suresh R, Erlichman C, Ivy SP, Suman V, Geyer SM, Fracasso PM, Cohen MS, et al. 17-allylaminogeldanamycin in advanced medullary and differentiated thyroid carcinoma. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 5582. PMID 28022079 DOI: 10.1200/jco.2011.29.15_suppl.5582  0.076
2012 Hussain N, Latif A, Shah MH. Coupled and tripled coincidence point results without compatibility Fixed Point Theory and Applications. 2012. DOI: 10.1186/1687-1812-2012-77  0.076
2016 Heilmann AM, Subbiah V, Wang K, Sun JX, Elvin JA, Chmielecki J, Sherman SI, Murthy R, Busaidy NL, Subbiah I, Yelensky R, Nangia C, Vergilio JA, Khan SA, Erlich RL, ... ... Shah MH, et al. Comprehensive Genomic Profiling of Clinically Advanced Medullary Thyroid Carcinoma. Oncology. PMID 27207748 DOI: 10.1159/000445978  0.074
2010 Akhter G, Ahmad Z, Iqbal J, Shaheen N, Shah MH. Physicochemical characterization of groundwater in urban areas of Lahore, Pakistan, with special reference to arsenic Journal of the Chemical Society of Pakistan. 32: 306-312.  0.074
2015 Van Loon K, Zhang L, Keiser J, Carrasco C, Glass K, Ramirez MT, Bobiak S, Nakakura EK, Venook AP, Shah MH, Bergsland EK. Bone metastases and skeletal-related events from neuroendocrine tumors. Endocrine Connections. 4: 9-17. PMID 25430999 DOI: 10.1530/Ec-14-0119  0.074
2015 Shah MH, Liu GS, Thompson EW, Dusting GJ, Peshavariya HM. Differential effects of superoxide dismutase and superoxide dismutase/catalase mimetics on human breast cancer cells. Breast Cancer Research and Treatment. 150: 523-34. PMID 25794772 DOI: 10.1007/s10549-015-3329-z  0.074
2001 Rawal RM, Patel PS, Vyas RK, Sainger RN, Shah MH, Peshavariya HM, Patel DD, Bhatavdekar JM. Role of pretherapeutic biomarkers in predicting postoperative radiotherapy response in patients with advanced squamous cell carcinoma. International Journal of Radiation Biology. 77: 1141-6. PMID 11683985 DOI: 10.1080/09553000110067788  0.073
2014 Haraldsdottir S, Janku F, Timmers C, Geyer S, Schaaf L, Sexton J, Thurmond J, Velez-Bravo V, Stepanek V, Bertino E, Kendra K, Mortazavi A, Subbiah V, Villalona-Calero M, Poi M, ... ... Shah M, et al. 461 A phase I trial of dabrafenib (BRAF inhibitor) and pazopanib in BRAF mutated advanced malignancies European Journal of Cancer. 50: 151. DOI: 10.1016/S0959-8049(14)70587-8  0.072
2011 Abuzakhm SM, Acre-Lara CE, Zhao W, Hitchcock C, Mohamed N, Arbogast D, Shah MH. Unusual metastases of gastrointestinal stromal tumor and genotypic correlates: Case report and review of the literature. Journal of Gastrointestinal Oncology. 2: 45-9. PMID 22811827 DOI: 10.3978/j.issn.2078-6891.2011.006  0.071
2015 Saleem M, Iqbal J, Akhter G, Shah MH. Spatial/temporal characterization and risk assessment of trace metals in Mangla reservoir, Pakistan Journal of Chemistry. 2015. DOI: 10.1155/2015/928019  0.07
2009 Shah MH, Sainger RN, Telang SD, Pancholi GH, Shukla SN, Patel PS. E-Cadherin truncation and sialyl Lewis-X overexpression in oral squamous cell carcinoma and oral precancerous conditions. Neoplasma. 56: 40-7. PMID 19152244  0.07
2013 Iqbal J, Shah MH. Health Risk Assessment of Metals in Surface Water from Freshwater Source Lakes, Pakistan Human and Ecological Risk Assessment. 19: 1530-1543. DOI: 10.1080/10807039.2012.716681  0.069
2018 Giordano TJ, Haugen B, Sherman SI, Shah MH, Caoili EM, Koenig RJ. Pioglitazone Therapy of PAX8-PPARγ Fusion Protein Thyroid Carcinoma. The Journal of Clinical Endocrinology and Metabolism. PMID 29373711 DOI: 10.1210/Jc.2017-02533  0.068
2018 Besse B, Subbiah V, Drilon A, Shah M, Wirth LJ, Bauer TM, Velcheti V, Lakhani N, Boni V, Solomon BJ, Johnson M, Park K, Patel J, Cabanillas ME, Sherman E, et al. Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 29: viii33. PMID 32136775 DOI: 10.1093/annonc/mdy269.103  0.068
2018 Oxnard GR, Drilon AE, Shah MH, Wirth LJ, Bauer TM, Velcheti V, Lakhani NJ, Besse B, Park K, Patel JD, Cabanillas ME, Sherman EJ, Gordon K, Smith S, Nguyen M, et al. Detection and clearance of RET variants in plasma cell free DNA (cfDNA) from patients (pts) treated with LOXO-292. Journal of Clinical Oncology. 36: 9048-9048. DOI: 10.1093/Annonc/Mdy269.103  0.068
2015 Shah MH, Deng L, Bennadji H, Fisher EM. Pyrolysis of Potassium-Doped Wood at the Centimeter and Submillimeter Scales Energy and Fuels. 29: 7350-7357. DOI: 10.1021/Acs.Energyfuels.5B01776  0.068
2010 Jhiang SM, Shah MH. Prospects for small interfering RNA therapeutics in thyroid cancer. Thyroid : Official Journal of the American Thyroid Association. 20: 1049-50. PMID 20883169 DOI: 10.1089/Thy.2010.1660  0.067
2020 Drilon A, Oxnard GR, Tan DSW, Loong HHF, Johnson M, Gainor J, McCoach CE, Gautschi O, Besse B, Cho BC, Peled N, Weiss J, Kim YJ, Ohe Y, Nishio M, ... ... Shah MH, et al. Efficacy of Selpercatinib in Fusion-Positive Non-Small-Cell Lung Cancer. The New England Journal of Medicine. 383: 813-824. PMID 32846060 DOI: 10.1056/Nejmoa2005653  0.067
2013 Ahmad I, Shah MH. Trichoderma and intercropping impact production, quality and corm rot disease of gladiolus grandiflorus Floriculture and Ornamental Biotechnology. 7: 86-93.  0.067
2013 Arrese D, McNally ME, Chokshi R, Feria-Arias E, Schmidt C, Klemanski D, Gregory G, Khabiri H, Shah M, Bloomston M. Extrahepatic disease should not preclude transarterial chemoembolization for metastatic neuroendocrine carcinoma. Annals of Surgical Oncology. 20: 1114-20. PMID 23456380 DOI: 10.1245/s10434-012-2786-4  0.067
2015 Onesti JK, Shirley LA, Saunders ND, Davidson GW, Dillhoff ME, Khabiri H, Guy GE, Dowell JD, Schmidt CR, Shah MH, Bloomston M. Elevated Alkaline Phosphatase Prior to Transarterial Chemoembolization for Neuroendocrine Tumors Predicts Worse Outcomes Journal of Gastrointestinal Surgery. DOI: 10.1007/s11605-015-2998-6  0.065
2011 Arrese D, Feria-Arias E, Khabiri H, Guy G, Schmidt CR, Shah MH, Bloomston M. Effect of extrahepatic disease on transarterial chemoembolization for metastatic carcinoid. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 283. PMID 27985651 DOI: 10.1200/jco.2011.29.4_suppl.283  0.065
2006 Clark OH, Ajani J, Benson AB, Byrd D, Doherty GM, Engstrom PF, Ettinger DS, Gibbs JF, Heslin MJ, Kandeel F, Kessinger A, Kulke MH, Kvols L, Nemcek AA, Olson JA, ... ... Shah MH, et al. Neuroendocrine tumors. Journal of the National Comprehensive Cancer Network : Jnccn. 4: 102-38. PMID 16451769  0.064
2015 Ilyas A, Ahmad H, Shah MH. Comparative Study of Elemental Concentrations in the Scalp Hair and Nails of Myocardial Infarction Patients Versus Controls from Pakistan. Biological Trace Element Research. 166: 123-35. PMID 25876087 DOI: 10.1007/s12011-015-0259-x  0.064
2013 Shah MH. Thyroid Cancer Research Boom Oncology Times. 35: 2-4. DOI: 10.1097/01.COT.0000437196.08121.E9  0.063
2020 Owen DH, Benner B, Pilcher C, Good L, Savardekar H, Norman R, Ghattas C, Shah M, Konda B, Verschraegen CF, Wesolowski R, Behbehani GK, Carson WE, Otterson GA. Deep and Durable Response to Nivolumab and Temozolomide in Small-Cell Lung Cancer Associated With an Early Decrease in Myeloid-Derived Suppressor Cells. Clinical Lung Cancer. PMID 33234490 DOI: 10.1016/j.cllc.2020.10.018  0.063
2015 Hakami NY, Wong H, Shah MH, Dusting GJ, Jiang F, Peshavariya HM. Smad-independent pathway involved in transforming growth factor β1-induced Nox4 expression and proliferation of endothelial cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 319-26. PMID 25428269 DOI: 10.1007/s00210-014-1070-5  0.063
2007 Bloomston M, Al-Saif O, Klemanski D, Pinzone JJ, Martin EW, Palmer B, Guy G, Khabiri H, Ellison EC, Shah MH. Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned. Journal of Gastrointestinal Surgery : Official Journal of the Society For Surgery of the Alimentary Tract. 11: 264-71. PMID 17458596 DOI: 10.1007/s11605-007-0089-z  0.062
2015 Peikari HR, Shah MH, Zakaria MS, Yasin NM, Elhissi A. The impacts of second generation e-prescribing usability on community pharmacists outcomes. Research in Social & Administrative Pharmacy : Rsap. 11: 339-51. PMID 25262599 DOI: 10.1016/j.sapharm.2014.08.011  0.061
2020 Kander EM, Shah MH, Zhou Y, Goyal A, Palmer JD, Owen DH, Shilo K, Patel G, Raval RR, Gonzalez J, Nguyen M, Olek E, Kherani J, Rothenberg SM, Konda B. Response to the Selective RET Inhibitor Selpercatinib (LOXO-292) in a Patient With RET Fusion-positive Atypical Lung Carcinoid. Clinical Lung Cancer. PMID 32660930 DOI: 10.1016/j.cllc.2020.06.011  0.061
2015 Martin del Campo SE, Levine KM, Mundy-Bosse BL, Grignol VP, Fairchild ET, Campbell AR, Trikha P, Mace TA, Paul BK, Jaime-Ramirez AC, Markowitz J, Kondadasula SV, Guenterberg KD, McClory S, Karpa VI, ... ... Shah MH, et al. The Raf Kinase Inhibitor Sorafenib Inhibits JAK-STAT Signal Transduction in Human Immune Cells. Journal of Immunology (Baltimore, Md. : 1950). 195: 1995-2005. PMID 26238487 DOI: 10.4049/Jimmunol.1400084  0.06
2007 Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft FüR Pharmazeutische Verfahrenstechnik E.V. 67: 166-74. PMID 17353118 DOI: 10.1016/j.ejpb.2007.01.001  0.058
2017 Patel S, Owen D, Schmidt CR, Kirschner LS, Phay J, Shirley L, Dillhoff M, Brock P, Espinosa A, Shah MH, Konda B. Favorable and Durable Response to Pazopanib in Metastatic Refractory Paraganglioma. Journal of Oncology Practice. JOP2017024984. PMID 28850312 DOI: 10.1200/JOP.2017.024984  0.056
1994 Sparano JA, Wiernik PH, Strack M, Leaf A, Becker NH, Sarta C, Carney D, Elkind R, Shah M, Valentine ES. Infusional cyclophosphamide, doxorubicin and etoposide in HIV-related non-Hodgkin's lymphoma: a follow-up report of a highly active regimen. Leukemia & Lymphoma. 14: 263-71. PMID 7950915 DOI: 10.3109/10428199409049677  0.055
2011 Hussain N, Shah MH, Kutbi MA. Coupled coincidence point theorems for nonlinear contractions in partially ordered quasi-metric spaces with a Q-function Fixed Point Theory and Applications. 2011. DOI: 10.1155/2011/703938  0.054
2015 Wells SA, Asa SL, Dralle H, Elisei R, Evans DB, Gagel RF, Lee N, Machens A, Moley JF, Pacini F, Raue F, Frank-Raue K, Robinson B, Rosenthal MS, Santoro M, ... ... Shah M, et al. Revised american thyroid association guidelines for the management of medullary thyroid carcinoma. Thyroid : Official Journal of the American Thyroid Association. 25: 567-610. PMID 25810047 DOI: 10.1089/thy.2014.0335  0.054
2012 Viganego F, O'Donoghue S, Eldadah Z, Shah MH, Rastogi M, Mazel JA, Platia EV. Effect of early diagnosis and treatment with percutaneous lead extraction on survival in patients with cardiac device infections. The American Journal of Cardiology. 109: 1466-71. PMID 22356796 DOI: 10.1016/j.amjcard.2012.01.360  0.054
2012 Shah MH, Simić S, Hussain N, Sretenović A, Radenović S. Common fixed points theorems for occasionally weakly compatible pairs on cone metric type spaces Journal of Computational Analysis and Applications. 14: 290-297.  0.053
2001 Sweet K, Martin E, Eng C, Shah M. Familial Basal Cell Carcinoma, Melanoma and Skin Hypersensitivity with GIST: A New Hereditary Neuroendocrine Syndrome Involving the SCF/KIT Pathway? International Journal On Disability and Human Development. 2: 161-167. DOI: 10.1515/Ijdhd.2001.2.3.161  0.053
2008 Petrocca F, Visone R, Onelli MR, Shah MH, Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini M, Cavazzini L, Volinia S, Alder H, Ruco LP, Baldassarre G, et al. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell. 13: 272-86. PMID 18328430 DOI: 10.1016/J.Ccr.2008.02.013  0.053
2009 Shah MH, Ringel MD. Follicular Thyroid Carcinoma Clinical Endocrine Oncology: Second Edition. 143-154. DOI: 10.1002/9781444300222.ch17  0.053
2016 Akbar F, Kutbi MA, Shah MH, Shafqat N. Random coupled and tripled best proximity results with cyclic contraction in metric spaces Journal of Nonlinear Science and Applications. 9: 940-956.  0.05
2006 Shah MH, Freud AG, Benson DM, Ferkitich AK, Dezube BJ, Bernstein ZP, Caligiuri MA. A phase I study of ultra low dose interleukin-2 and stem cell factor in patients with HIV infection or HIV and cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3993-6. PMID 16818697 DOI: 10.1158/1078-0432.Ccr-06-0268  0.05
2011 Hussain N, Shah MH, Radenović S. Fixed points of weakly contractions through occasionally weak compatibility Journal of Computational Analysis and Applications. 13: 532-543.  0.049
2020 Egger ME, Armstrong E, Martin RC, Scoggins CR, Philips P, Shah M, Konda B, Dillhoff M, Pawlik TM, Cloyd JM. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis. Journal of the American College of Surgeons. PMID 32032719 DOI: 10.1016/J.Jamcollsurg.2019.12.026  0.049
2013 Jamliya RH, Deshmukh V, Rajesh C, Maliwad J, Shah BJ, Shah MH. Effect of adding dexmedetomidine in intrathecal bupivacaine versus intrathecal bupivacaine alone on spinal block characteristics in orthopaedic lower limb procedures [A Comparative Study] Research Journal of Pharmaceutical, Biological and Chemical Sciences. 4: 1340-1346.  0.049
2012 Shah MH, Hussain N. Nonlinear contractions in partially ordered quasi b-metric spaces Communications of the Korean Mathematical Society. 27: 117-128. DOI: 10.4134/CKMS.2012.27.1.117  0.048
2011 Ahmed R, Shah MH. Insights into the practice of expert simulation modellers 23rd European Modeling and Simulation Symposium, Emss 2011. 289-298.  0.048
2011 Aziz MKA, Morad NA, Wambeck N, Shah MH. Optimizing palm biomass energy though size reduction 2011 4th International Conference On Modeling, Simulation and Applied Optimization, Icmsao 2011. DOI: 10.1109/ICMSAO.2011.5775516  0.046
2008 Pearson AC, Steinberg S, Shah MH, Bloomston M. The complicated management of a patient following transarterial chemoembolization for metastatic carcinoid. World Journal of Surgical Oncology. 6: 125. PMID 19032771 DOI: 10.1186/1477-7819-6-125  0.045
2012 Iqbal J, Shah MH, Tirmizi SA, Akhter G. Evaluation of water quality for drinking and irrigation purpose from Simly Lake, Pakistan Journal of the Chemical Society of Pakistan. 34: 1565-1572.  0.045
2011 Shah SIH, Bokhari RH, Hassan S, Shah MH, Shah MA. Socio-technical factors affecting ERP implementation success in Pakistan: An empirical study Australian Journal of Basic and Applied Sciences. 5: 742-749.  0.043
2009 Matrka LA, Wakely P, Ozer E, Shah M, Meacham R. Management of Neuroendocrine Carcinoma of the Head and Neck The Laryngoscope. 119: S71-S71. DOI: 10.1002/LARY.20348  0.043
2011 Cho YJ, Shah MH, Hussain N. Coupled fixed points of weakly F-contractive mappings in topological spaces Applied Mathematics Letters. 24: 1185-1190. DOI: 10.1016/j.aml.2011.02.004  0.043
2003 Shah MH, Porcu P, Mallery SR, Caligiuri MA. AIDS-associated malignancies Cancer Chemotherapy and Biological Response Modifiers. 21: 717-746. PMID 15338771 DOI: 10.1016/s0921-4410(03)21034-6  0.042
2010 Hesketh GG, Shah MH, Halperin VL, Cooke CA, Akar FG, Yen TE, Kass DA, Machamer CE, Van Eyk JE, Tomaselli GF. Ultrastructure and regulation of lateralized connexin43 in the failing heart. Circulation Research. 106: 1153-63. PMID 20167932 DOI: 10.1161/Circresaha.108.182147  0.04
2010 Khan AR, Shah MH, Hussain N. Common fixed points of weakly contractive and strongly expansive mappings in topological spaces Journal of Inequalities and Applications. 2010. DOI: 10.1155/2010/746045  0.039
2016 Kazmi SA, Khan S, Khalifa OO, Shah MH. Spectrum analysis of physiological signals of human activities Proceedings of 2015 International Conference On Emerging Technologies, Icet 2015. DOI: 10.1109/ICET.2015.7389197  0.039
2014 Khan N, Abbasi AM, Dastagir G, Nazir A, Shah GM, Shah MM, Shah MH. Ethnobotanical and antimicrobial study of some selected medicinal plants used in Khyber Pakhtunkhwa (KPK) as a potential source to cure infectious diseases. Bmc Complementary and Alternative Medicine. 14: 122. PMID 24708514 DOI: 10.1186/1472-6882-14-122  0.038
2011 Shah MH, Chen X, Chauhan AK. Does consumer believe on advertisers? the evaluation of advertising skepticism in India and China Asian Social Science. 7: 26-36.  0.037
2013 Arif S, Iqbal J, Shaheen N, Shah MH. Comparative evaluation of trace elements in the blood of chronic bronchitis patients and healthy donors Trace Elements and Electrolytes. 30: 122-129. DOI: 10.5414/TEX01289  0.037
2015 Shah MH, Peikari HR. Electronic Prescribing Usability: Reduction of Mental Workload and Prescribing Errors Among Community Physicians. Telemedicine Journal and E-Health : the Official Journal of the American Telemedicine Association. PMID 26244488 DOI: 10.1089/tmj.2014.0246  0.036
2013 Peikari HR, Zakaria MS, Yasin NM, Shah MH, Elhissi A. Role of computerized physician order entry usability in the reduction of prescribing errors. Healthcare Informatics Research. 19: 93-101. PMID 23882414 DOI: 10.4258/hir.2013.19.2.93  0.035
2021 Bauml J, Mick R, Mccoach C, Weiss J, Marrone K, Nieva J, Villaruz L, Levy B, Moreno R, Murkherji R, Sun F, Schwartzman W, Shaverdashvili K, Wang X, Shah M, et al. FP14.06 Multicenter Analysis of Mechanisms of Resistance to Osimertinib (O) in EGFR Mutated NSCLC: An ATOMIC Registry Study Journal of Thoracic Oncology. 16: S229-S230. DOI: 10.1016/J.JTHO.2021.01.149  0.035
2013 Kodaganur SG, Tontanahal SJ, Sarda A, Shah MH, Bhat V, Kumar A. Clinical phenotype and the lack of mutations in the CHRNG, CHRND, and CHRNA1 genes in two Indian families with Escobar syndrome. Clinical Dysmorphology. 22: 54-8. PMID 23448903 DOI: 10.1097/Mcd.0B013E32835F9Ac0  0.035
2010 Shah MH. Bilateral linkages with OECD and FDI inflows in leading developing countries International Journal of Interdisciplinary Social Sciences. 5: 255-269.  0.035
2014 Shah MH, Bhat V, Shetty JS, Kumar A. Whole exome sequencing identifies a novel splice-site mutation in ADAMTS17 in an Indian family with Weill-Marchesani syndrome. Molecular Vision. 20: 790-6. PMID 24940034  0.034
2014 Shah MH, Peikari HR, Yasin NM. The determinants of individuals' perceived e-security: Evidence from Malaysia International Journal of Information Management. 34: 48-57. DOI: 10.1016/j.ijinfomgt.2013.10.001  0.033
2010 Lam ET, Kloos RT, Ringel MD, Wei L, Shah MH. Reply to A. Machens et al Journal of Clinical Oncology. 28: e535-e536. DOI: 10.1200/JCO.2010.30.0426  0.033
2010 Shah MH. Limits of pure functionals of C*-algebras Journal of Operator Theory. 63: 349-362.  0.032
2014 Shah MH, Hussain N, Ćirić L. Existence of fixed points of mappings on general topological spaces Filomat. 28: 1237-1246. DOI: 10.2298/FIL1406237S  0.031
2004 Quayle AJ, Shah M, Cu-Uvin S, Politch JA, Chou C, Anderson DJ, Tuomala R, Crowley-Nowick PA, Duerr A. Implications of blood contamination for assessment of local cellular immunity in the endocervix. Aids Research and Human Retroviruses. 20: 543-6. PMID 15186529 DOI: 10.1089/088922204323087796  0.031
2006 Veshapidze G, Trachy ML, Shah MH, DePaola BD. Reducing the uncertainty in laser beam size measurement with a scanning edge method. Applied Optics. 45: 8197-9. PMID 17068562 DOI: 10.1364/Ao.45.008197  0.03
2007 Trachy ML, Veshapidze G, Shah MH, Jang HU, DePaola BD. Photoassociation in cold atoms via ladder excitation. Physical Review Letters. 99: 043003. PMID 17678360 DOI: 10.1103/PhysRevLett.99.043003  0.03
2013 Singh R, Shah DB, Gohil AM, Shah MH. Overall equipment effectiveness (OEE) calculation - Automation through hardware & software development Procedia Engineering. 51: 579-584. DOI: 10.1016/j.proeng.2013.01.082  0.03
2015 Abbasi AM, Shah MH, Li T, Fu X, Guo X, Liu RH. Ethnomedicinal values, phenolic contents and antioxidant properties of wild culinary vegetables. Journal of Ethnopharmacology. 162: 333-45. PMID 25571845 DOI: 10.1016/j.jep.2014.12.051  0.029
2007 Shah MH, Villalona-Calero MA, Marcucci G, Byrd JC, Grever MR. HDAC Inhibitors and Cardiac Safety Clinical Cancer Research. 13: 1068.2-1068. DOI: 10.1158/1078-0432.CCR-06-2380  0.028
2006 Khatri VP, Shah MH, Petrelli NJ, Li Y, Beckett L, Gibbs JF, Rodriguez-Bigas MA. Type-2 dominant cytokine gene expression following hepatic surgery. Journal of Hepato-Biliary-Pancreatic Surgery. 13: 442-9. PMID 17013720 DOI: 10.1007/S00534-006-1103-7  0.028
2016 Soomro ZA, Shah MH, Ahmed J. Information security management needs more holistic approach: A literature review International Journal of Information Management. 36: 215-225. DOI: 10.1016/j.ijinfomgt.2015.11.009  0.027
2015 Shah MH, Kazmi SA, Sidek KA, Khan S, Iqbal FTZ. Power spectrum density based analysis of photolythsmographic signal for different physiological conditions 2014 Ieee International Conference On Smart Instrumentation, Measurement and Applications, Icsima 2014. DOI: 10.1109/ICSIMA.2014.7047435  0.026
2013 Abbasi AM, Khan MA, Khan N, Shah MH. Ethnobotanical survey of medicinally important wild edible fruits species used by tribal communities of Lesser Himalayas-Pakistan. Journal of Ethnopharmacology. 148: 528-36. PMID 23665057 DOI: 10.1016/j.jep.2013.04.050  0.026
2016 Haraldsdottir S, Bertino E, Haglund K, Kaffenberger B, Shah MH. Radiation Recall Dermatitis With Concomitant Dabrafenib and Pazopanib Therapy. Jama Dermatology. PMID 26886900 DOI: 10.1001/jamadermatol.2015.5366  0.026
2020 Verma N, Shah M, Ghalib L, Kirschner L, Endo M, Konda B. CLO20-064: A Case Series of Ectopic Cushing Syndrome in Atypical Lung Carcinoid Journal of the National Comprehensive Cancer Network. 18: CLO20-064. DOI: 10.6004/jnccn.2019.7500  0.025
2014 Shah MH, Kazmi SA, Sidek KA, Khan S, Iqbal FTZ. Photoplethysmographic based heart rate variability for different physiological conditions 2014 Ieee Student Conference On Research and Development, Scored 2014. DOI: 10.1109/SCORED.2014.7072998  0.025
2015 Shah MH. Looking past today. Journal of the Medical Association of Georgia. 104: 3. PMID 26492736  0.024
2014 Shah MH, Rahneva N, Ahmed R. Knowledge management practice at a Bulgarian bank: A case study International Journal of Knowledge Management. 10: 54-69. DOI: 10.4018/ijkm.2014070104  0.024
2013 Abbasi AM, Khan MA, Shah MH, Shah MM, Pervez A, Ahmad M. Ethnobotanical appraisal and cultural values of medicinally important wild edible vegetables of Lesser Himalayas-Pakistan. Journal of Ethnobiology and Ethnomedicine. 9: 66. PMID 24034131 DOI: 10.1186/1746-4269-9-66  0.024
2014 Usman M, Shah MH, Badar A, Fatima B, Sabir M, Zaman Q. Media steaming and coco-coir enhance growth of rough lemon (Citrus Jambhiri L.) stock Pakistan Journal of Agricultural Sciences. 51: 615-623.  0.024
2016 Galukande M, Wabinga H, Mirembe F, Karamagi C, Asea A, Jordan B, Jahn F, Müller-Tidow C, Jordan K, Beckmann J, Unverzagt S, Wang K, Erlich RL, Lipson D, Ross JS, ... ... Shah MH, et al. Contents Vol. 90, 2016 Oncology. 90. DOI: 10.1159/000447033  0.024
2013 Shah MH. Mobile working: Technologies and business strategies Mobile Working: Technologies and Business Strategies. 1-125. DOI: 10.4324/9781315885292  0.023
2007 Khoumbati K, Shah SG, Dwivedi YK, Shah MH. Evaluation of investment for enterprise application integration technology in healthcare organisations: a cost-benefit approach. International Journal of Electronic Healthcare. 3: 453-67. PMID 18048277 DOI: 10.1504/IJEH.2007.015323  0.022
2011 Hussain N, Shah MH. KKM mappings in cone b-metric spaces Computers and Mathematics With Applications. 62: 1677-1684. DOI: 10.1016/j.camwa.2011.06.004  0.022
2015 Mehmood Abbasi A, Shah MH, Guo X, Khan N. Comparison of Nutritional Value, Antioxidant Potential, and Risk Assessment of the Mulberry (Morus) Fruits International Journal of Fruit Science. DOI: 10.1080/15538362.2015.1061960  0.02
2015 Usman M, Bakhsh K, Fatima B, Zaman Q, Shah MH. Exploring embryogenic competence in anthers of bitter gourd (Momordica charantia l.) cultivar faisalabad long Journal of Animal and Plant Sciences. 25: 181-188.  0.018
2014 Amasiatu CV, Shah MH. First party fraud: A review of the forms and motives of fraudulent consumer behaviours in e-tailing International Journal of Retail and Distribution Management. 42: 805-817. DOI: 10.1108/IJRDM-05-2013-0112  0.017
2013 Usman AK, Shah MH. Critical success factors for preventing E-banking fraud Journal of Internet Banking and Commerce. 18.  0.016
2014 Mohammadi Doostdar H, Shah MH, Sattari H. A Stylish Burial: Tracking the Socio-Technical Aspects of Death in Iran Journal of Development Studies. 50: 855-863. DOI: 10.1080/00220388.2014.895820  0.015
2015 Shah MH. It's time we get EHR on a truly "meaningful" track. Journal of the Medical Association of Georgia. 104: 3. PMID 26665996  0.015
2007 Quayle AJ, Kourtis AP, Cu-Uvin S, Politch JA, Yang H, Bowman FP, Shah M, Anderson DJ, Crowley-Nowick P, Duerr A. T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. Journal of Acquired Immune Deficiency Syndromes (1999). 44: 292-8. PMID 17146371 DOI: 10.1097/QAI.0b013e31802c5b3a  0.013
2015 Shah MH, Sidek KA, Khan S, Kazmi SA, Kadir KA. Measurement of Photoplythsmography signal for Heart Rate Variability and comparison of two different age groups Conference Record - Ieee Instrumentation and Measurement Technology Conference. 2015: 1981-1986. DOI: 10.1109/I2MTC.2015.7151586  0.011
2015 Shah MH. Prior authorization: Undermining our health care system. Journal of the Medical Association of Georgia. 104: 3. PMID 26489270  0.01
2014 Shah MH. House of delegates inaugural address. Journal of the Medical Association of Georgia. 103: 3. PMID 25665368  0.01
2013 Shah MH, Saqib MA. Swot analysis of MA educational planning and management programme of Allama Iqbal open university, Islamabad Turkish Online Journal of Distance Education. 14: 120-137.  0.01
2013 Usman M, Samad WA, Fatima B, Shah MH. Pollen parent enhances fruit size and quality in intervarietal crosses in guava (Psidium guajava) International Journal of Agriculture and Biology. 15: 125-129.  0.01
1998 Shah MH, Hackshaw KV, Caligiuri MA, McInnes LB, Leung BP, Feng G.- J, Sturrock RD, Field M, Liew FY. A role for IL-15 in rheumatoid arthritis? [1] (multiple letters) Nature Medicine. 4: 643. PMID 9623950 DOI: 10.1038/Nm0698-643A  0.01
Hide low-probability matches.